Influence of female sex and fertile age on neuromyelitis optica spectrum disorders

Multiple Sclerosis

Volumn 23, Issue 8, 2017, Pages 1092-1103

  Borisow, Nadja ^a   Kleiter, Ingo ^b   Gahlen, Anna ^b   Fischer, Katrin ^c   Wernecke, Klaus Dieter ^a   Pache, Florence ^a   Ruprecht, Klemens ^a   Havla, Joachim ^d   Krumbholz, Markus ^d   Kümpfel, Tania ^d   Aktas, Orhan ^e   Ringelstein, Marius ^e   Geis, Christian ^g,h   Kleinschnitz, Christoph ^f   Berthele, Achim ⁱ   Hemmer, Bernhard ^i,j   Angstwurm, Klemens ^k   Weissert, Robert ^k   Stellmann, Jan Patrick ^l   Schuster, Simon ^l   Stangel, Martin ^m   Lauda, Florian ⁿ   Tumani, Hayrettin ⁿ   Mayer, Christoph ^o   Zeltner, Lena ^p   Ziemann, Ulf ^p   Linker, Ralf A ^q   Schwab, Matthias ^h   Marziniak, Martin ^r,s   Then Bergh, Florian ^t   Hofstadt Van Oy, Ulrich ^u,v   Neuhaus, Oliver ^w   Winkelmann, Alexander ^x   Marouf, Wael ^c   Rückriem, Lioba ^y   Faiss, Jürgen ^c   Wildemann, Brigitte ^z   Paul, Friedemann ^a   Jarius, Sven ^z   Trebst, Corinna ^m   Hellwig, Kerstin ^b   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c Asklepios Fachklinikum Teupitz ^*  (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^h JENA UNIVERSITY HOSPITAL   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^l UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^m HANNOVER MEDICAL SCHOOL   (Germany)

ⁿ UNIVERSITY OF ULM   (Germany)

^o GOETHE UNIVERSITY   (Germany)

^p UNIVERSITY OF TÜBINGEN   (Germany)

^q UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^r UNIVERSITY OF MÜNSTER   (Germany)

^s Isar Amper Hospital   (Germany)

^t UNIVERSITY OF LEIPZIG   (Germany)

^u INSTITUTE OF PATHOLOGY   (Germany)

^v Klinikum Westfalen   (Germany)

^w SRH Krankenhaus Sigmaringen   (Germany)

^x UNIVERSITY OF ROSTOCK   (Germany)

^y MediClin Hedon Klinik   (Germany)

^z UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

age factors; aquaporin 4; Neuromyelitis optica; sex

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; GLATIRAMER; MITOXANTRONE; RITUXIMAB; STEROID; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; ALEMTUZUMAB; CYCLOSPORINE; FINGOLIMOD; IMMUNOGLOBULIN; METHOTREXATE; NATALIZUMAB; TOCILIZUMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG MEGADOSE; EPIDEMIOLOGY; FEMALE; FEMALE FERTILITY; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; PATHOPHYSIOLOGY; PREVALENCE; REMISSION; SEX DIFFERENCE; TREATMENT RESPONSE; AGE DISTRIBUTION; FERTILITY; GENETICS; IMMUNOLOGY; MIDDLE AGED; ONSET AGE; SEXUAL CHARACTERISTICS; YOUNG ADULT; AGE; AGING; FERTILE AGE; RISK FACTOR; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AQUAPORIN 4; AUTOANTIBODIES; FEMALE; FERTILITY; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 85046087506     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458516671203     Document Type: Article

References (35)

1. Jarius S, Wildemann B, Paul F,. Neuromyelitis optica: Clinical features, immunopathogenesis and treatment. Clin Exp Immunol 2014; 176: 149-164.
2. Wingerchuk DM,. Neuromyelitis optica: Effect of gender. J Neurol Sci 2009; 286: 18-23.
3. Mealy MA, Wingerchuk DM, Greenberg BM, et al. Epidemiology of neuromyelitis optica in the United States: A multicenter analysis. Arch Neurol 2012; 69: 1176-1180.
4. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 2012; 9: 14.
5. Siritho S, Apiwattanakul M, Nakashima I, et al. Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: A comparison with seropositive cases. J Neurol Sci 2014; 341: 17-21.
6. Wingerchuk DM, Weinshenker BG,. Neuromyelitis optica clinical predictors of a relapsing course and survival. Neurology 2003; 60: 848-853.
7. Lisnevskaia L, Murphy G, Isenberg D,. Systemic lupus erythematosus. Lancet 2014; 384: 1878-1888.
8. Bove R, Chitnis T,. Sexual disparities in the incidence and course of MS. Clin Immunol Orlando Fla 2013; 149: 201-210.
9. Schwendimann RN, Alekseeva N,. Gender issues in multiple sclerosis. Int Rev Neurobiol 2007; 79: 377-392.
10. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
11. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
12. Poetzsch O, Weinmann J, Haustein T,. Birth trends and the family situation in Germany. Report, Federal Statistical Office, Wiesbaden, Germany, 2012.
13. Stepaniak U, Szafraniec K, Kubinova R, et al. Age at natural menopause in three central and eastern European urban populations: The HAPIEE study. Maturitas 2013; 75: 87-93.
14. Kleiter I, Gahlen A, Borisow N, et al. Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses. Ann Neurol 2016; 79: 206-216.
15. Dahmen G, Ziegler A,. Generalized estimating equations in controlled clinical trials: Hypotheses Testing. Biom J 2004; 46: 214-232.
16. Alamanos Y, Voulgari PV, Siozos C, et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J Rheumatol 2003; 30: 731-735.
17. Huppke B, Ellenberger D, Rosewich H, et al. Clinical presentation of pediatric multiple sclerosis before puberty. Eur J Neurol 2014; 21: 441-446.
18. Cossburn M, Ingram G, Hirst C, et al. Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Mult Scler Houndmills Basingstoke Engl 2012; 18: 45-54.
19. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71: 93-100.
20. Uzawa A, Mori M, Hayakawa S, et al. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol Off J Eur Fed Neurol Soc 2010; 17: 672-676.
21. Kleiter I, Hellwig K, Berthele A, et al. Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol 2012; 69: 239-245.
22. Trebst C, Jarius S, Berthele A, et al. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014; 261: 1-16.
23. López P, Mozo L, Gutiérrez C, et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: Gender and age influence on immunological features. Lupus 2003; 12: 860-865.
24. Borba EF, Araujo DB, Bonfá E, et al. Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: Comparison with other populations. Lupus 2013; 22: 744-749.
25. Akman-Demir G, Tüzün E, Waters P, et al. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol 2011; 258: 464-470.
26. Huppke P, Blüthner M, Bauer O, et al. Neuromyelitis optica and NMO-IgG in European pediatric patients. Neurology 2010; 75: 1740-1744.
27. McCombe PA, Greer JM, Mackay IR,. Sexual dimorphism in autoimmune disease. Curr Mol Med 2009; 9: 1058-1079.
28. Ponsonby A-L, Lucas RM, van der Mei IA, et al. UVR, vitamin D and three autoimmune diseases-Multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol 2005; 81: 1267-1275.
29. Voskuhl RR, Gold SM,. Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 2012; 8: 255-263.
30. Furman D, Hejblum BP, Simon N, et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A 2014; 111: 869-874.
31. Batrinos ML,. Premenopause: The endocrinology of reproductive decline. Horm Athens Greece 2013; 12: 334-349.
32. Athreya BH, Pletcher J, Zulian F, et al. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro. Clin Immunol Immunopathol 1993; 66: 201-211.
33. Kovats S,. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol 2015; 294: 63-69.
34. Kalincik T, Buzzard K, Jokubaitis V, et al. Risk of relapse phenotype recurrence in multiple sclerosis. Mult Scler Houndmills Basingstoke Engl 2014; 20: 1511-1522.
35. West T, Wyatt M, High A, et al. Are initial demyelinating event recovery and time to second event under differential control? Neurology 2006; 67: 809-813.